Cardiac Sympathetic Imaging With mIBG in Heart Failure
Author(s) -
Ignasi Carrió,
Martín Cowie,
Junichi Yamazaki,
James E. Udelson,
Paolo G. Camici
Publication year - 2010
Publication title -
jacc. cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.79
H-Index - 120
eISSN - 1936-878X
pISSN - 1876-7591
DOI - 10.1016/j.jcmg.2009.07.014
Subject(s) - heart failure , medicine , cardiology , cardiac imaging , cardiomyopathy , sympathetic nervous system , sympathetic innervation , sympathetic activity , heart rate , blood pressure
Cardiac sympathetic imaging with meta-iodobenzylguanidine (mIBG) is a noninvasive tool to risk stratify patients with heart failure (HF). In patients with ischemic and nonischemic cardiomyopathy, cardiac mIBG activity is a very powerful predictor of survival. Cardiac sympathetic imaging can help in understanding how sympathetic overactivity exerts its deleterious actions, which may result in better therapy and outcome for patients with HF.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom